Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
Quick Stats
Feb 02, 202638.9
AI Score
SELL0.83
Volume Ratio
Next Earnings
9
+ve Days (30d)
20
-ve Days (30d)
BGMS Stock Summary
Last updated Feb 02, 2026
BGMS is currently trading at $1.13, positioned below its 200-day moving average of $None, suggesting bearish momentum. The stock has a 52-week range of $0.215 to $19.8663.
Technical Analysis: The 50-day moving average stands at $1.43, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.128, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.351, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BGMS at 38.9/100 with a SELL recommendation.
BGMS (Bio Green Med Solution, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 33.128 |
| CMF (20) | -0.351 |
| ROC (10) | -29.375 |
| ADX (14) | 18.234 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.067 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -98.189 |
| MFI (14) | 39.752 |
BGMS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BGMS Price vs Max Options Open Interest
BGMS Max Change In Options Open Interest
BGMS Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BGMS Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BGMS Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BGMS Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Bio Green Med Solution, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BGMS Moving Averages Analysis
BGMS (Bio Green Med Solution, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 1.3 |
| 20 | 1.35 |
| 30 | 1.39 |
| 50 | 1.43 |
| 100 | 2.51 |
| 200 | None |
BGMS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | -- |
| Earnings/Share ($) | -- |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |